Intravenous Antibiotic Treatment at Home
ConditionInfection
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorHelse Møre og Romsdal HF
About this trial
The purpose of the study is to develop and evaluate a new model for across services interaction with the use of welfare technology and telemedicine. The model includes innovative and new routines for the exchange of patient information, quality systems and procedures between the municipality and the hospital. This model will first be tested for use in intravenous antibiotic therapy. The results of the study will be used to further develop the service. In the larger context, it is desirable to provide knowledge that is transferable to other diagnostic groups, treatment methods and geographical areas.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Competent to give consent
The infection can not be treated with oral antibiotics in monotherapy
Selected IV antibiotics must be suitable for administration via selected pumps
The patient's condition is stable and does not require frequent observation by health care professionals
Disqualifiers
consent not given
Trial population
Patients participate in both study part 1 (qualitative) and study part 2 (quantitative). Health professionals and next to kins participate in study part 1 (qualitative).
Trial design
Design model
Other
Time perspective
Cross-sectional
Treatments tested in this trial
A new model of interaction across health services with use of welfare technology and telemedicine
Other interventionInstead of admitted to the hospital, patients are followed up at home by the municipal regional response center and nurses in the response team according to the individual treatment plan. Hospital physicians are medically responsible throughout the course.
Treatment groups
50 Participants
are divided into 3 treatment groupsGroup A: Patients needing antibiotics infusion1 intervention
Group B: Next of kin1 intervention
Group C: Health professionals1 intervention
Trial outcomes
Primary outcomes
1
number of rehospitalisations
Time frame
45 months2
patient satisfaction
assessed with semi-structured interview
Time frame
45 months3
health personnel's opinion on patient safety
based on answers in web-case-registration-form (CRF)
Time frame
45 monthsSponsors and contacts
Click on the lead sponsor to view all of their trials.
Helse Møre og Romsdal HF
Lead sponsor
SINTEF Health Research
Collaborator
Kristiansund municipality
Collaborator
Centre for Health Innovation
Collaborator
Hospital Pharmacy of Central Norway Trust
Collaborator
Source ClinicalTrials.gov